Citations (75)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Jane Kriengkauykiat, James I Ito & Sanjeet S Dadwal. (2011) Epidemiology and treatment approaches in management of invasive fungal infections. Clinical Epidemiology 3, pages 175-191.
Read now
Read now
Hiroto Narimatsu & Masahiro Kami. (2008) Management of fungal infections following allogeneic stem cell transplantation. Expert Review of Anti-infective Therapy 6:3, pages 373-384.
Read now
Read now
B.E. De Pauw. (2001) Treatment of Documented and Suspected Neutropenia-Associated Invasive Fungal Infections. Journal of Chemotherapy 13:sup4, pages 181-192.
Read now
Read now
Michael R. Jeng & James Feusner. (2001) ITRACONAZOLE-ENHANCED VINCRISTINE NEUROTOXICITY IN A CHILD WITH ACUTE LYMPHOBLASTIC LEUKEMIA. Pediatric Hematology and Oncology 18:2, pages 137-142.
Read now
Read now
T. Lamy, M. Bernard, A. Courtois, C. Jacquelinet, S. Chevrier, C. Dauriac, I. Grulois, C. Guiguen & PY. Le Prise. (1998) Prophylactic Use of Itraconazole for the Prevention of Invasive Pulmonary Aspergillosis in High Risk Neutropenic Patients. Leukemia & Lymphoma 30:1-2, pages 163-174.
Read now
Read now
T.J. Walsh, B. de Pauw, E. Anaissie & P. Martino. (1994) Recent advances in the epidemiology, prevention and treatment of invasive fungal infections in neutropenic patients. Journal of Medical and Veterinary Mycology 32:sup1, pages 33-51.
Read now
Read now
Articles from other publishers (69)
Cho-Hao Lee, Chin Lin, Ching-Liang Ho & Jung-Chung Lin. (2018) Primary Fungal Prophylaxis in Hematological Malignancy: a Network Meta-Analysis of Randomized Controlled Trials. Antimicrobial Agents and Chemotherapy 62:8.
Crossref
Crossref
Johan A Maertens, Corrado Girmenia, Roger J Brüggemann, Rafael F Duarte, Christopher C Kibbler, Per Ljungman, Zdeněk Racil, Patricia Ribaud, Monica A Slavin, Oliver A Cornely, J Peter Donnelly & Catherine Cordonnier. (2018) European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia. Journal of Antimicrobial Chemotherapy.
Crossref
Crossref
Rachel Pounds, Sarah Leonard, Christopher Dawson & Sean Kehoe. (2017) Repurposing itraconazole for the treatment of cancer. Oncology Letters 14:3, pages 2587-2597.
Crossref
Crossref
Hiroshi Tsubamoto, Tomoko Ueda, Kayo Inoue, Kazuko Sakata, Hiroaki Shibahara & Takashi Sonoda. (2017) Repurposing itraconazole as an anticancer agent. Oncology Letters 14:2, pages 1240-1246.
Crossref
Crossref
Peter C Gøtzsche & Helle Krogh Johansen. (2014) Routine versus selective antifungal administration for control of fungal infections in patients with cancer. Cochrane Database of Systematic Reviews 2017:3.
Crossref
Crossref
Michelle Science, Paula D. Robinson, Tamara MacDonald, Shahrad Rod Rassekh, L. Lee Dupuis & Lillian Sung. (2014) Guideline for primary antifungal prophylaxis for pediatric patients with cancer or hematopoietic stem cell transplant recipients. Pediatric Blood & Cancer 61:3, pages 393-400.
Crossref
Crossref
Petros Pechlivanoglou, Hoa H. Le, Simon Daenen, John A. Snowden & Maarten J. Postma. (2014) Mixed treatment comparison of prophylaxis against invasive fungal infections in neutropenic patients receiving therapy for haematological malignancies: a systematic review. Journal of Antimicrobial Chemotherapy 69:1, pages 1-11.
Crossref
Crossref
Ben de Pauw & Marta Stanzani. 2011. Principles and Practice of Cancer Infectious Diseases. Principles and Practice of Cancer Infectious Diseases
533
540
.
Panayiotis D. Ziakas, Irene S. Kourbeti, Michael Voulgarelis & Eleftherios Mylonakis. (2010) Effectiveness of Systemic Antifungal Prophylaxis in Patients With Neutropenia After Chemotherapy: A Meta-Analysis of Randomized Controlled Trials. Clinical Therapeutics 32:14, pages 2316-2336.
Crossref
Crossref
Rajesh V. Lalla, Marie C. Latortue, Catherine H. Hong, Anura Ariyawardana, Sandra D’Amato-Palumbo, Dena J. Fischer, Andrew Martof, Ourania Nicolatou-Galitis, Lauren L. Patton, Linda S. Elting, Fred K. L. Spijkervet & Michael T. Brennan. (2010) A systematic review of oral fungal infections in patients receiving cancer therapy. Supportive Care in Cancer 18:8, pages 985-992.
Crossref
Crossref
Rafael de la Cámara, José Mensa, Enric Carreras, Manuel Cuenca Estrella, José Ángel García Rodríguez, Miguel Gobernado, Juan Picazo, José María Aguado & Miguel Ángel Sanz. (2010) Profilaxis antifúngica en pacientes oncohematológicos: revisión de la bibliografía médica y recomendaciones. Medicina Clínica 134:5, pages 222-233.
Crossref
Crossref
Martha Donoghue, Nita L. Seibel, Peter S. Francis & Thomas J. Walsh. 2009. Clinical Mycology. Clinical Mycology
561
589
.
Eyal Robenshtok, Anat Gafter-Gvili, Elad Goldberg, Miriam Weinberger, Moshe Yeshurun, Leonard Leibovici & Mical Paul. (2007) Antifungal Prophylaxis in Cancer Patients After Chemotherapy or Hematopoietic Stem-Cell Transplantation: Systematic Review and Meta-Analysis. Journal of Clinical Oncology 25:34, pages 5471-5489.
Crossref
Crossref
Johan A. Maertens, Pascale Frère, Cornelia Lass-Flörl, Werner Heinz & Oliver A. Cornely. (2007) Primary antifungal prophylaxis in leukaemia patients. European Journal of Cancer Supplements 5:2, pages 43-48.
Crossref
Crossref
Jan E Clarkson, Helen V Worthington & Tim OB Eden. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Janet E Clarkson, Helen V Worthington & Tim OB Eden. (2007) Interventions for preventing oral candidiasis for patients with cancer receiving treatment. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Anne K Due, Helle K Johansen & Peter C Gøtzsche. (2006) Fungal infection-related mortality versus total mortality as an outcome in trials of antifungal agents. BMC Medical Research Methodology 6:1.
Crossref
Crossref
M. Kami, N. Murashige, Y. Tanaka & H. Narimatsu. (2006) Antifungal prophylaxis following reduced-intensity stem cell transplantation. Transplant Infectious Disease 8:4, pages 190-202.
Crossref
Crossref
O. Penack, S. Schwartz, P. Martus, M. Reinwald, M. Schmidt-Hieber, E. Thiel & I.W. Blau. (2006) Low-dose liposomal amphotericin B in the prevention of invasive fungal infections in patients with prolonged neutropenia: results from a randomized, single-center trial. Annals of Oncology 17:8, pages 1306-1312.
Crossref
Crossref
I Oren, J M Rowe, H Sprecher, A Tamir, N Benyamini, L Akria, A Gorelik, N Dally, T Zuckerman, N Haddad, R Fineman & E J Dann. (2006) A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients. Bone Marrow Transplantation 38:2, pages 127-134.
Crossref
Crossref
Jason T. McConville, Kirk A. Overhoff, Prapasri Sinswat, Jason M. Vaughn, Bradi L. Frei, David S. Burgess, Robert L. Talbert, Jay I. Peters, Keith P. Johnston & Robert O. WilliamsIIIIII. (2006) Targeted High Lung Concentrations of Itraconazole Using Nebulized Dispersions in a Murine Model. Pharmaceutical Research 23:5, pages 901-911.
Crossref
Crossref
Axel Glasmacher, Oliver Cornely, Andrew J. Ullmann, Ulrich Wedding, Heinrich Bodenstein, Hannes Wandt, Christian Boewer, Rita Pasold, Hans-Heinrich Wolf, Mathias Hänel, Gottfried Dölken, Christian Junghanss, Reinhard Andreesen & Hartmut Bertz. (2006) An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia. Journal of Antimicrobial Chemotherapy 57:2, pages 317-325.
Crossref
Crossref
Masahiro Kami & Tomoko Matsumura. (2006) Fungal Infection Following Reduced-Intensity Stem Cell Transplantation (RIST). Nippon Ishinkin Gakkai Zasshi 47:3, pages 143-153.
Crossref
Crossref
HV Worthington, OB Eden & JE Clarkson. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Francesco Menichetti. (2004) How to Improve the Design of Trials of Antifungal Prophylaxis among Neutropenic Adults with Acute Leukemia. Clinical Infectious Diseases 39:Supplement_4, pages S181-S184.
Crossref
Crossref
A P Grigg, M Brown, A W Roberts, J Szer & M A Slavin. (2004) A pilot study of targeted itraconazole prophylaxis in patients with graft-versus-host disease at high risk of invasive mould infections following allogeneic stem cell transplantation. Bone Marrow Transplantation 34:5, pages 447-453.
Crossref
Crossref
David A. Stevens. (2004) Azoles in the Management of Systemic Fungal Infections. Infectious Diseases in Clinical Practice 12:2, pages 81-92.
Crossref
Crossref
Gloria N. Mattiuzzi, Hagop Kantarjian, Stefan Faderl, JoAnn Lim, Dimitrios Kontoyiannis, Deborah Thomas, William Wierda, Isaam Raad, Guillermo Garcia‐Manero, Xian Zhou, Alexandra Ferrajoli, Nebiyou Bekele & Elihu Estey. (2004) Amphotericin B lipid complex as prophylaxis of invasive fungal infections in patients with acute myelogenous leukemia and myelodysplastic syndrome undergoing induction chemotherapy. Cancer 100:3, pages 581-589.
Crossref
Crossref
M. N. Neely, D. J. Sheehan & M. A. Ghannoum. 2004. Human Fungal Pathogens. Human Fungal Pathogens
299
318
.
Axel GlasmacherArchibald PrenticeMarcus GorschlüterSteffen EngelhartCorinna HahnBenjamin DjulbegovicIngo G.H. Schmidt-Wolf. (2003) Itraconazole Prevents Invasive Fungal Infections in Neutropenic Patients Treated for Hematologic Malignancies: Evidence From a Meta-Analysis of 3,597 Patients. Journal of Clinical Oncology 21:24, pages 4615-4626.
Crossref
Crossref
Oliver A. CornelyAndrew J. UllmannMeinolf Karthaus. (2003) Evidence-based assessment of primary antifungal prophylaxis in patients with hematologic malignancies. Blood 101:9, pages 3365-3372.
Crossref
Crossref
Kürşat Kaptan, Ali Uğur Ural, Türker Çetin, Ferit Avcu, Cengiz Beyan & Atilla Yalçin. (2003) Itraconazole is not effective for the prophylaxis of fungal infections in patients with neutropenia. Journal of Infection and Chemotherapy 9:1, pages 40-45.
Crossref
Crossref
Eric J. Bow, Michel Laverdière, Nathalie Lussier, Coleman Rotstein, Mary S. Cheang & Stratis Ioannou. (2002) Antifungal prophylaxis for severely neutropenic chemotherapy recipients. Cancer 94:12, pages 3230-3246.
Crossref
Crossref
Peter C Gøtzsche & Helle Krogh Johansen. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
L. Joseph Wheat, Mitchell Goldman & George A. Sarosi. 2002. Clinical Approach to Infection in the Compromised Host. Clinical Approach to Infection in the Compromised Host
215
247
.
Candis Morrison & Edward Lew. (2001) Aspergillosis. American Journal of Nursing 101:8, pages 40-48.
Crossref
Crossref
Marc Boogaerts & Johan Maertens. (2001) Clinical Experience with Itraconazole in Systemic Fungal Infections. Drugs 61:Supplement 1, pages 39-47.
Crossref
Crossref
Jacques F.G.M. Meis & Paul E. Verweij. (2001) Current Management of Fungal Infections. Drugs 61:Supplement 1, pages 13-25.
Crossref
Crossref
B. de Pauw. (2000) Is there a need for new antifungal agents?. Clinical Microbiology and Infection 6, pages 23-28.
Crossref
Crossref
Preeti N. Malani & Carol A. Kauffman. (2000) Prevention and prophylaxis of invasive fungal sinusitis in the immunocompromised patient. Otolaryngologic Clinics of North America 33:2, pages 301-312.
Crossref
Crossref
M. Nucci, I. Biasoli, T. Akiti, F. Silveira, C. Solza, G. Barreiros, N. Spector, A. Derossi & W. Pulcheri. (2000) A Double-Blind, Randomized, Placebo-Controlled Trial of Itraconazole Capsules as Antifungal Prophylaxis for Neutropenic Patients. Clinical Infectious Diseases 30:2, pages 300-305.
Crossref
Crossref
A. Glasmacher, C. Hahn, C. Leutner, E. Molitor, E. Wardelmann, C. Losem, T. Sauerbruch, G. Marklein & I. G. H. Schmidt-Wolf. (1999) Breakthrough invasive fungal infections in neutropenic patients after prophylaxis with itraconazole. Mycoses 42:7-8, pages 443-451.
Crossref
Crossref
Cristiana M. Toscano & William R. Jarvis. (1999) Emerging issues in nosocomial fungal infections. Current Infectious Disease Reports 1:4, pages 347-361.
Crossref
Crossref
Jean Klastersky, Stephen Schimpff & Hans-Jörg SennBen De Pauw. 1999. Supportive Care In Cancer. Supportive Care In Cancer
49
85
.
A. Glasmacher, C. Hahn, E. Molitor, T. Sauerbruch, I. G. H. Schmidt-Wolf & G. Marklein. (1999) <tocheading>Original Article</tocheading>. Mycoses 42:5-6, pages 395-402.
Crossref
Crossref
Godfrey R. Morgenstern, Archibald G. Prentice, H. Grant Prentice, Janet E. Ropner, Stephen A. Schey & David W. Warnock. (2005) A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. British Journal of Haematology 105:4, pages 901-911.
Crossref
Crossref
P. C. Huijgens, A. M. Simoons-Smit, A. C. van Loenen, E. Prooy, H. van Tinteren, G. J. Ossenkoppele & A. R. Jonkhoff. (1999) Fluconazole versus itraconazole for the prevention of fungal infections in haemato-oncology. Journal of Clinical Pathology 52:5, pages 376-380.
Crossref
Crossref
Christine L. Terrell. (1999) Antifungal Agents. Part II. The Azoles. Mayo Clinic Proceedings 74:1, pages 78-100.
Crossref
Crossref
Gary A. Noskin. 1998. Management of Infectious Complications in Cancer Patients. Management of Infectious Complications in Cancer Patients
223
246
.
U. S. Schuler & C. Haag. (1997) Prophylaxis of fungal infections. Mycoses 40, pages 41-44.
Crossref
Crossref
O LortholaryB Dupont. (1997) Antifungal prophylaxis during neutropenia and immunodeficiency. Clinical Microbiology Reviews 10:3, pages 477-504.
Crossref
Crossref
J.P. DONNELLY. (1997) Is there a rationale for the use of antimicrobial prophylaxis in neutropenic patients?. Journal of Internal Medicine 242, pages 79-88.
Crossref
Crossref
Markus Ruynke & Jörg Beyer. (1997) Antimykotische Prophylaxe bei neutropenischen und immunsupprimierten PatientenAntimycotic prophylaxis in neutropenic and immunsuppressed patients. Medizinische Klinik 92:1, pages 28-36.
Crossref
Crossref
B. E. Pauw. (1997) Practical modalities for prevention of fungal infections in cancer patients. European Journal of Clinical Microbiology & Infectious Diseases 16:1, pages 32-41.
Crossref
Crossref
G. P. Bodey. 1997. Febrile Neutropenia. Febrile Neutropenia
89
98
.
J. Beyer, S. Schwartz, G. Behre, K. Lenz, W.-D. Ludwig, W. Hiddemann & W. Siegert. 1997. Acute Leukemias VI. Acute Leukemias VI
485
488
.
A. De Laurenzi, A. Matteocci, A. Lanti, L. Pescador, F. Blandino & C. Papetti. (1996) Amphotericin B prophylaxis against invasive fungal infections in neutropenic patients: A single center experience from 1980 to 1995Amphotericin B zur Prophylaxe gegen invasive Pilzinfektionen bei neutropenischen Patienten: Erfahrungen in einem Zentrum aus den Jahren 1980–1995. Infection 24:5, pages 361-366.
Crossref
Crossref
John Philpott-Howard. (1996) Prevention of Fungal Infections in Hematology Patients. Infection Control and Hospital Epidemiology 17:8, pages 545-551.
Crossref
Crossref
John Philpott-Howard. (2015) Prevention of Fungal Infections in Hematology Patients. Infection Control & Hospital Epidemiology 17:8, pages 545-551.
Crossref
Crossref
A. Glasmacher, E. Molitor, J. Mezger & G. Marklein. (1996) Antifungal prophylaxis with itraconazole in neutropenic patients: pharmacological, microbiological and clinical aspects. Mycoses 39:7-8, pages 249-258.
Crossref
Crossref
I. W. Blau & A. A. Fauser. (1996) Antimykotische Prophylaxe in der protrahierten Neutropenie und der allogenen Knochenmarktransplantation. Mycoses 39, pages 81-86.
Crossref
Crossref
M.A. Boogaerts. (1996) Antifungal prophylaxis in neutropenic patients. International Journal of Antimicrobial Agents 6:3, pages 149-154.
Crossref
Crossref
A. Böhme, A. Ganser & D. Hoelzer. (1995) Aggravation of vincristine-induced neurotoxicity by itraconazole in the treatment of adult ALL. Annals of Hematology 71:6, pages 311-312.
Crossref
Crossref
G. F. Behre, S. Schwartz, K. Lenz, W. -D. Ludwig, H. Wandt, E. Schilling, V. Heinemann, H. Link, A. Trittin, O. Boenisch, W. Treder, W. Siegert, W. Hiddemann & J. Beyer. (1995) Aerosol amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in neutropenic cancer patients. Annals of Hematology 71:6, pages 287-291.
Crossref
Crossref
U. Schuler, M. Mölle & G. Ehninger. (1995) Prophylaxe und Therapie von Pilzinfektionen in der Onkologie. Mycoses 38, pages 45-50.
Crossref
Crossref
B. E. de Pauw, J. M. M. Raemaekers, J. P. Donnelly, B. -J. Kullberg & J. F. G. M. Meis. (1995) An open study on the safety and efficacy of fluconazole in the treatment of disseminated Candida infections in patients treated for hematological malignancy. Annals of Hematology 70:2, pages 83-87.
Crossref
Crossref
Thomas J. Walsh & Caron A. Lyman. 1995. Infectious Complications of Cancer. Infectious Complications of Cancer
113
148
.
J. Peter Donnelly. 1995. Infectious Complications of Cancer. Infectious Complications of Cancer
45
81
.
J BeyerS SchwartzV HeinemannW Siegert. (1994) Strategies in prevention of invasive pulmonary aspergillosis in immunosuppressed or neutropenic patients. Antimicrobial Agents and Chemotherapy 38:5, pages 911-917.
Crossref
Crossref